首页 | 本学科首页   官方微博 | 高级检索  
检索        

中药治疗糖尿病足溃疡随机对照试验的系统评价
引用本文:张惠敏,廖星,韩梅,李树法,赵建勇,刘建平.中药治疗糖尿病足溃疡随机对照试验的系统评价[J].北京中医药大学学报,2012,35(6):412-418,421.
作者姓名:张惠敏  廖星  韩梅  李树法  赵建勇  刘建平
作者单位:北京中医药大学基础医学院 北京100029;中国中医科学院中医临床基础医学研究所;北京中医药大学循证医学中心;贵阳市第一人民医院
基金项目:北京中医药大学基本科研业务费资助项目
摘    要:目的评价中药治疗糖尿病足溃疡的疗效和安全性。方法采用循证医学系统评价的方法。检索策略:电子检索数据库MEDLINE、CNKI、VIP、CBM、Cochrane图书馆(2010年第3期)。检索日期截止2011年1月31日。纳入标准:中药与安慰剂对照、不治疗、局部或全身使用抗感染药物比较治疗糖尿病足溃疡的随机对照试验(RCT)。试验组和对照组均允许采用西医常规治疗。资料提取与分析:两人独立提取资料,采用Cochrane协作网提供的软件RevMan 5.0.17进行资料分析。结局的效应指标为相对危险度(relative risk,RR)或均数差(mean difference,MD),均以95%可信区间表示。结果纳入的14篇研究涉及893名糖尿病足溃疡患者用于评估。纳入的2篇英文文献质量较高,中文文献质量普遍偏低。在溃疡愈合率>50%上:中药结合常规治疗组优于常规治疗组(RR:1.33;95%CI1.04,1.70]),中药结合常规治疗优于西药结合常规治疗组(RR:1.38;95%CI:1.14,1.67]);在溃疡完全愈合上:中药结合常规治疗组优于西药结合常规治疗组(RR:1.89;95%CI:1.42,2.51]);在溃疡愈合时间(周)上:中药治疗结合常规治疗优于安慰剂结合常规治疗(MD:-3.30;95%CI:-4.03,-2.57])。中药治疗未发现严重不良事件。结论目前证据表明中药对糖尿病足溃疡愈合可能具有潜在的疗效,需要设计更为严谨的大样本临床试验进行验证。

关 键 词:中药  糖尿病足溃疡  随机对照试验  系统综述

Systematic evaluation on randomized controlled trials in treatment of diabetic foot ulcer with Chinese medicinals
ZHANG Hui-min , LIAO Xing , HAN Mei , LI Shu-fa , ZHAO Jian-yong , LIU Jian-ping.Systematic evaluation on randomized controlled trials in treatment of diabetic foot ulcer with Chinese medicinals[J].Journal of Beijing University of Traditional Chinese Medicine,2012,35(6):412-418,421.
Authors:ZHANG Hui-min  LIAO Xing  HAN Mei  LI Shu-fa  ZHAO Jian-yong  LIU Jian-ping
Institution:1 School of Preclinical Medicine,Beijing University of Chinese Medicine,Beijing 100029;2 Institute of Chinese Basic Clinical Medicine,China Academy of Chinese Medical Sciences;3 Center for Evidence-Based Chinese Medicine,Beijing University of Chinese Medicine;4 Guiyang Municipal First People’s Hospital)
Abstract:Objective To review the curative effect and safety of Chinese medicinals in treatment of diabetic foot ulcer.Methods The systematic evaluation of evidence-based medicine was used.The retrieval strategy was as follows: MEDLINE,CNKI,VIP,CBM and Cochrane Library(issue 3,2010) were retrieved.The deadline was Jan.31,2011.The inclusion criteria was as follows: randomized controlled trials(RCT) of treating diabetic foot ulcer including control of Chinese medicinals and placebo,comparison among non-specific treatment,local treatment and systemic treatment with anti-infective drugs.Experimental group and control group were all allowed to use the conventional therapy of Western medicine.The extraction and analysis of data were as follows: data were extracted by two persons independently and analyzed by using RevMan 5.0.17 software provided by Cochrane Collaboration.The resultant effective indexes included relative risk(RR) and mean difference(MD) manifested as 95% confidence interval(95% CI).Results There were 14 studies reviewed involving 893 patients with diabetic foot ulcer,among which 2 literature in English were higher in the quality and the quality of other literature in Chinese was poor.In ulcer healing rate being over 50%,the group with Chinese medicinals combining conventional therapy had better results compared with the group with conventional therapy,and also had better results compared with the group with Western medicinals combining conventional therapy.In ulcer completely healing,the group with Chinese medicinals combining conventional therapy had better results compared with the group with Western medicinals combining conventional therapy.In ulcer healing time(week),the group with Chinese medicinals combining conventional therapy had better results compared with the group with placebo combining conventional therapy.There were no severe adverse events observed in the treatment with Chinese medicinals.Conclusion The current evidence shows that Chinese medicinals have the latent curative effect in the healing of diabetic foot ulcer,which needs to be confirmed through designing more rigorous clinical expreriment with larger sample.
Keywords:Chinese medicinals  diabetic foot ulcer  randomized controlled trials  systematic reviews
本文献已被 CNKI 万方数据 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号